BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Genetown

  Atea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527) Novel Mechanism of Action Against SARS-CoV-2 in Nature Communications

  Atea Pharmaceuticals, Inc. today announced that new data highlighting bemnifosbuvir (AT-527) were published in the peer-reviewed journal, Nature Communications.

  February 2, 2022

   · 

  6 min read
• Phenylketonuria Treatment Market Growth Opportunity Analysis Report

  The phenylketonuria treatment market has been experiencing the rapid growth opportunities in the upcoming years.

  February 2, 2022

   · 

  8 min read
• Oncology Companion Diagnostic Market Size, Scope, Segmentation and Key Players

  Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients.

  February 2, 2022

   · 

  6 min read
• Gastroesophageal Reflux Disease (GERD) Devices Market Key Drivers and New Developments

  The drive for clinical procedures and devices in the management of gastroesophageal reflux disease stemmed from the wide prevalence of the condition.

  February 2, 2022

   · 

  6 min read
• Bullous Pemphigoid Treatment Market: Rise in the prevalence of bullous pemphigoid across the world to drive the market

  Bullous pemphigoid is a rare autoimmune inflammatory skin disease that causes large, fluid-filled blisters on the skin.

  February 2, 2022

   · 

  5 min read
• Spago Nanomedical Year-End Report January-December, 2021

  The regulatory preclinical program with Tumorad® (177Lu-SN201) were completed and show a good safety margin for clinically relevant doses.

  February 2, 2022

   · 

  5 min read
• Medtronic announces first procedure in Europe with Hugo™ robotic-assisted surgery system

  Medtronic plc, a global leader in healthcare technology, and OLV Hospital Aalst announced that the first clinical procedure in Europe was performed with the Hugo™ robotic-assisted surgery system.

  February 2, 2022

   · 

  6 min read
• Genetown

  Tango Therapeutics to Participate in Upcoming Investor Conferences in February 2022

  Tango Therapeutics, Inc., a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced that members of the management team are scheduled to participate in the following upcoming virtual investor conferences in February.

  February 2, 2022

   · 

  1 min read